GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.
For investor information, please contact IR@genmarkdx.com.
Aug 13, 2014 at 9:30 AM ET
Canaccord Genuity 34th Annual Growth Conference
Aug 11, 2014 at 4:30 PM ET
GenMark Diagnostics Second Quarter Earnings